Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Extended‐field chemoradiotherapy vs pelvic chemoradiotherapy

Late adverse events

It is very uncertain whether extended‐field chemoradiotherapy changes late adverse events compared with pelvic chemoradiotherapy (very low certainty).

1 finding from 1 review

Extended‐field radiotherapy for locally advanced cervical cancer 2018 · Cochrane Headline outcomes only
RR 0.95 [0.06, 14.59]
1 study · 74 participants
Very low

Extended‐field radiotherapy vs pelvic chemoradiotherapy

Late adverse events

Extended‐field radiotherapy showed no clear difference in late adverse events compared with pelvic chemoradiotherapy (moderate certainty).

1 finding from 1 review

Extended‐field radiotherapy for locally advanced cervical cancer 2018 · Cochrane Headline outcomes only
RR 1.06 [0.69, 1.62]
1 study · 386 participants
Moderate